

#5682
Mentioned in 5 episodes
Malignant
How Bad Policy and Bad Evidence Harm People with Cancer
Book • 2020
In 'Malignant', Dr. Vinayak K. Prasad critiques the current state of oncology, highlighting issues such as lax regulatory standards, financial conflicts of interest, and the overemphasis on surrogate endpoints in clinical trials.
He argues for reforms to ensure that cancer drugs provide meaningful benefits at lower costs.
The book offers insights into how cancer trials are conducted and how drugs are approved, proposing solutions to improve cancer medicine.
He argues for reforms to ensure that cancer drugs provide meaningful benefits at lower costs.
The book offers insights into how cancer trials are conducted and how drugs are approved, proposing solutions to improve cancer medicine.
Mentioned by
Mentioned in 5 episodes
Mentioned by 

as the author of the book, highlighting his expertise in the field.


Bari Weiss

73 snips
Will Ozempic Solve Obesity in America? A Debate
Mentioned by 

as a book he is currently reading, focusing on public health policy and cancer.


Bob Kaplan

20 snips
#103 - Looking back on the first 99 episodes: Strong Convictions, Loosely Held
Mentioned by ![undefined]()

as the book that discusses the state of cancer research and pharmaceuticals.

Vinay Prasad

12 snips
Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Mentioned by 

in the introduction, referencing Dr. ![undefined]()

's previous appearance on the show.


Russ Roberts

Vinay Prasad

Vinay Prasad on the Pandemic
Mentioned by 

as ![undefined]()

's book published this year, focusing on oncology.


Peter Attia

Vinay Prasad

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy
Mentioned by 

as the subject of the EconTalk episode and author of the book.


Russ Roberts

Vinay Prasad on Cancer Drugs, Medical Ethics, and Malignant